Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Common antidepressant may change brain differently in depressed and non-depressed people

  • Extra hour of screen time per day associated with poorer GCSE grades

  • How protein tangles accumulate in brain, cause neurological disorders

  • Artificial intelligence authors crowdsourced interactive fiction

  • Neighbors, but not classmates

  • IV administration of endothelin B receptor drug reduces memory loss, oxidative stress in Alzheimer's disease

  • Highly effective seasickness treatment on the horizon

  • Making effective use of voluntary help

  • Tracking down the causes of Alzheimer's

  • New model of cognitive flexibility gives insight into autism spectrum disorder

  •